Development of a RIPK1 degrader to enhance antitumor immunity.Published in:Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-55006-2By:Yu, Xin;Lu, Dong;Qi, Xiaoli;Paudel, Rishi Ram;Lin, Hanfeng;Holloman, Bryan L.;Jin, Feng;Xu, Longyong;Ding, Lang;Peng, Weiyi;Wang, Meng C.;Chen, Xi;Wang, JinPublication type:Article